Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standardized diagnosis and treatment strategy for post-stroke depression
ChiCTR-OCH-13003133Phase 4Completed
- Sponsor
- Zhongda Hospital, Southeast University
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of antidepressant (TDDS/ODF) in major depressive disorder (MDD) (3 arms), sponsored by Zhongda Hospital, Southeast University. Primary endpoints: Neuropsychological assessment and Biochemical indicators. Started Sep 2012; status: completed.
02
Drugs
antidepressant (TDDS/ODF)
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR-OCH-13003133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OCH-13003133.